Endo > SM_189b: Calcium / Parathyroid / Bone Basic > Flashcards

SM_189b: Calcium / Parathyroid / Bone Basic Flashcards

(84 cards)

Study These Flashcards
1
Q

Describe the functions of Ca

A

Ca functons

  • Regulation of excitable tissues
  • Secretion
  • Coagulation
  • Enzymatic activity
  • Signal transduction
  • Formation and maintenance of the skeleton
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hypocalcemia results in ___

A

Hypocalcemia results in increased neuromuscular excitability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hypercalcemia results in ___, ___, ___, ___, ___, and ___

A

Hypercalcemia results in dehydration, renal stones, pain, weakness, confusion, and cardiac arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Normal serum Ca is ___

A

Normal serum Ca is 8.5-10.4 mg/dL

  • Serum Ca generally fluctuates no more than 0.2 mg/dL in either direction throughout the day
  • Tight homeostatic control is a consequence of feedback regulation between Ca and PTH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Calcium and PTH have an ___ effect

A

Calcium and PTH have an opposing effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Most serum Ca is ___

A

Most serum Ca is ionized

  • Ionized (50%): mediates biological responses
  • Complex with anions (10%): phosphate, citrate
  • Protein bound (40%): 90% with albumin, remainder with globulins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Intestinal Ca absorption is promoted by ____ and ____

A

Intestinal Ca absorption is promoted by facilitated diffusion through the small intestin and Vitamin D dependent transport of Ca and P

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Calcium loss through the intestine can result from ____, ____, and ____

A

Calcium loss through the intestine can result from

  • Glucocorticoids: decrease Ca absorption
  • Mucosal and biliary secretion
  • Steatorrhea, diarrhea, and malabsorption syndromes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ca absorption is increased by ____

A

Ca absorption is increased by PTH

(at distal nephron)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Calcium excretion is increased by ____, ____, and ____

A

Calcium excretion is increased by loop diuretics, dietary protein, and glucocorticoids

Loop diuretics (furosemide, ethacrynic acid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Thiazide diuretics ____ calcium excretion

A

Thiazide diuretics decrease calcium excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Phosphate excretion is increased by ____ and ____

A

Phosphate excretion is increased by PTH and FGF-23

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

___ is major site of Ca storage in the body

A

Bone is major site of Ca storage in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe Ca handling in bone

A

Ca handling in bone

  • Bone is major site of Ca storage in body: Ca stored largely in a crystalline form resembling hydroxyapatite
  • Stable pool is regulated by cellular activity, affected by hormones, cytokines, growth factors, and drugs
  • Exchangeable pool provides buffering and acid-base balance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe roles of bone

A

Roles of bone

  • Metabolic: Ca homeostasis, buffering
  • Structural: supports body, protects internal organs
  • Cell development and maturation: bone marrow is site of hematopoiesis, provides bone cell precursors, and produces cytokines that affect bone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Appendicular bone is ___

A

Appendicular bone is largely compact cortical bone with some trabecular regions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Axial bone is ____

A

Axial bone is thin cortex, largely trabecular, and highly connected bony plates

  • Contains more marrow and fat
  • Trabecular bone has highest activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ca is regulated in the ____, ____, and ____

A

Ca is regulated in the intestine, kidney, and bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Osteoclasts secrete ____ and ____ to ____

A

Osteoclasts secrete H+ and proteolytic enzymes to degrade bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

RANKL / TRANCE is a ____ produced by ____

A

RANKL / TRANCE is a membrane-associated cytokine produced by osteoblasts and other cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

RANKL acts on the ___ receptor on osteoclasts and osteoclast precursors

A

RANKL acts on the RANKL receptor on osteoclasts and osteoclast precursors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

RANKL promotes ____, ____, ____, and ____

A

RANKL promotes fusion, differentiation, activity, and survival of osteoclasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Osteoblasts secrete ____, ____, ____, and ____

A

Osteoblasts secrete collagen, other matrix proteins, growth factors, and cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

____ is 90% of the protein of the boen matrix (osteoid)

A

Collagen is 90% of the protein of the boen matrix (osteoid)

  • Osteiod + hydroxyapatite = mineralized matrix
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
\_\_\_\_, \_\_\_\_, and ____ are products used as markers of osteoblastic activity
Osteocalcin, alkaline phosphatase, and collagen peptides cleaved off during synthesis are products used as markers of osteoblastic activity
26
\_\_\_\_, \_\_\_\_, and ____ are osteoblast products that affect osteoclasts
Selected cytokines (IL-6), RANKL, and osteoprotegerin (RANKL antagonist) are osteoblast products that affect osteoclasts
27
\_\_\_\_ are the source of osteoblasts
Pluripotent precursors are the source of osteoblasts (can also give rise to adipocytes, chondrocytes, and myocytes)
28
\_\_\_\_, \_\_\_\_, and ____ promote osteoblast differentiation and activity
Wnt signaling, insulin-like growth factor 1, and bone morphogenic proteins promote osteoblast differentiation and activity
29
Osteoblasts become ____ as bone forms around the osteoblasts
Osteoblasts become osteocytes as bone forms around the osteoblasts
30
Describe osteocytes
Osteocytes * Comprise 90% of the cells of bone * Sense mechanical load * Connect with other cells of bone * Produce sclerostin (protein) that inhibits wnt signaling and osteoblast differentiation
31
Sclerostin is produced by ____ and inhibits ____ and \_\_\_\_
Sclerostin is produced by osteocytes and inhibits wnt signaling and osteoblast differentiation
32
Sclerostin ____ increase bone formation
Sclerostin antagonists increase bone formation
33
Bone remodeling activity is ____ and involves \_\_\_\_
Bone remodeling activity is continual and involves sequential activity of osteoclasts and osteoblasts
34
Osteoporosis is \_\_\_\_
Osteoporosis is a systematic condition in which osteoblastic activity cannot keep pace with accelerated osteoclastic activity, resulting in the loss of mineral and matrix and increased susceptibility to fracture
35
Paget's disease of bone is \_\_\_
Paget's disease of bone is a disorder in which locally increased osteoclastic activity is followed by increased osteoblastic activity, resulting in abnormal bone
36
Vitamin D is \_\_\_
Vitamin D is a secosteroid produced in the skin by action of UV light on 7-dehydrocholesterol * Vitamins D2 and D3 have differences in side chain * Vitamin D2 is produced by plants and fungi * Vitamin D3 is produced by animals
37
Vitamin D is converted to ____ in the liver
Vitamin D is converted to 25-(OH)-D in the liver
38
Final activation step for Vitamin D is ____ and occurs in the \_\_\_\_
Final activation step for Vitamin D is 1-hydroxylation and occurs in the kidney * Stimulated by PTH * Stimulated by low serum phosphate * Tightly feedback regulated
39
Active metabolite of Vitamin D3 is \_\_\_\_
Active metabolite of Vitamin D3 is 1,25(OH)2D3 (calcitriol) * Considered a hormone / endocrine because it is synthesized at one site in the body and travels through the bloodstream to target sites
40
Describe calcitriol actions
Calcitriol actions * Effects produced through nuclear receptors * Stimulates intestinal Ca and P absorption -\> bone mineralization * Suppresses PTH secretion
41
In excess, calcitriol can cause ____ through ____ and \_\_\_\_
In excess, calcitriol can cause hypercalcemia through excess Ca and P absorption and direct actions on osteoblasts to increase RANKL
42
Describe uses of Vitamin D
Vitamin D uses * Use related to its effects on Ca and P absorption * Treatment of nutritional rickets * Treatment of ricks and osteomalacia due to inadequate 1-hydroxylation of 25-OH-D: Vitamin D resistant rickets, VDRR, renal disease, and hypoparathyroidism * Adequate Vitamin D is important adjunct to other therapy in patients with osteoporosis
43
Describe Vitamin D analogues with unique properties
Vitamin D analogues with unique properties * Alphacalcidol (1alpha-hydroxyvitamin D3): does not require 1-hydroxylation, useful when 1-hydroxylase is deficient * Paracalcitol: suppresses PTH, minimal effects on intestine, useful for secondary hyperparathyroidism * Calcipotriol: effective topically, used for psoriasis
44
Describe PTH
PTH * 84 amino acid peptide * Derived from a larger peptide by processing steps in the ER and Golgi * Normally secreted at least partially in a pulsatile manner * An analogue, 1-34 PTH (teriparatide), has full activity
45
Calcium ____ regulates release of PTH via the \_\_\_\_
Calcium negatively regulates release of PTH via the Ca-sensing receptor
46
Calcimimetics act on the ___ to reduce PTH secretion
Calcimimetics act on the Ca sensing receptor to reduce PTH secretion
47
Calcitriol and analogs ____ release of PTH
Calcitriol and analogs inhibit release of PTH
48
Cinacalcet is a \_\_\_
Cinacalcet is a calcimimetic
49
Calcimimetics (Cinacalcet) act by ___ and \_\_\_
Calcimimetics (Cinacalcet) act by allosterically activating the CaSR and enhancing the sensitivity of CaSR * Enhanced sensitivity of CaSR: lowers [Ca] at which PTH is suppressed
50
Cinacalcet is used to \_\_\_\_
Cinacalcet is used to suppress PTH in hyperparathyroidism or parathyroid carcinoma * Calcimemtic * Orally effective, metabolized by CYPs, renal excretion * Side effects: hypocalcemia, adynamic bone disease
51
PTH acts through ____ in ____ and \_\_\_\_
PTH acts through GPCRs in bone (osteoblasts and osteocytes) and kidney * PKA and PKC pathways are stimulated
52
PTH acts on the kidney to \_\_\_, \_\_\_, and \_\_\_
PTH acts on the kidney to * Increase Ca absorption * Decrease phosphate reabsorption * Stimulate 1alpha-hydroxylation of 25-OH-D to form 1,25-(OH)2D3
53
PTH effects on the intestine are \_\_\_\_, mediated through the \_\_\_\_
PTH effects on the intestine are indirect, mediated through the increase in 1,25-(OH)2D3
54
Bone ___ results from continuous exposure to PTH
Bone resorption results from continuous exposure to PTH * Resorption is largely due to increased RANKL
55
Bone ___ results from intermittent exposure to PTH
Bone formation results from intermittent exposure to PTH * Mechanisms: decreased osteoblast apoptosis, increased osteoblast differentiation, and suppression of sclerostin production
56
Teriparatide (PTH 1-34) is an ____ agent for the treatment of \_\_\_\_
Teriparatide (PTH 1-34) is an anabolic agent for the treatment of osteoporosis * Administered by subcutaneous injection only daily * Concerns: hypercalcemia, osteosarcoma (not seen in humans)
57
Parathyroid hormone related peptide \_\_\_\_, \_\_\_\_, and \_\_\_\_
Parathyroid hormone related peptide is an etiologic factor in the hypercalcemia of malignancy and in osteolytic metastases of breast cancer, effects on mammary glands / placenta / smooth muscle, and anabolic actions on bone * Abaloparatide is PHTHrP analog
58
Calcitonin is secreted by ____ after stimulation by \_\_\_\_
Calcitonin is secreted by C-cells of thryoid gland after stimulation by calcium
59
Calcitonin acts on ____ through GPCRs to \_\_\_\_
Calcitonin acts on mature osteoclasts through GPCRs to inhibit bone resorption * Antiresorptive * Useful for Paget's disease
60
Fibroblast growth factor 23 is produced by ____ and ____ and its synthesis is increased by ____ and \_\_\_\_
Fibroblast growth factor 23 is produced by osteoblasts and osteocytes and its synthesis is increased by calcitriol and phosphate
61
Fibroblast growth factor 23 functions to \_\_\_
Fibroblast growth factor 23 functions to inhibit renal calcitriol synthesis and phosphate reabsorption
62
Describe pathophysiology resulting from low/high FGF-23
Pathophysiology resulting from low/high FGF-23 * Tumoral calcinosis results from mutations that inhibit FGF 23 secretion * Hypophosphatemic rickets result from mutations in a cleavage site required for FGF 23 inactivation
63
Estrogen is important for maintenance of \_\_\_\_
Estrogen is important for maintenance of bone * Decreased estrogen at menopause accelerates bone loss
64
Estrogen is ____ and \_\_\_\_
Estrogen is antiresorptive and anabolic * Inhibits production of RANKL and IL-6 * Increases production of osteoprotegerin * Causes apoptosis of osteoclasts * Decreases sclerostin, promoting bone formation
65
Androgens are aromatized to ____ in bone and act on \_\_\_\_
Androgens are aromatized to estrogen in bone and act onestrogen receptors
66
\_\_\_\_ has been reported in males with aromatase deficiency or who lack estrogen receptors
Osteoporosis has been reported in males with aromatase deficiency or who lack estrogen receptors
67
Raloxifene is a \_\_\_
Raloxifene is a selective estrogen response modulator
68
Selective estrogen response modulators (raloxifene) interacts with \_\_\_\_
Selective estrogen response modulators (raloxifene) interacts with estrogen receptors in a tissue-specific manner * Estrogenic actions on bone (largely antiresorptive) * Anti-estrogenic effects on the mammary gland
69
Selective estrogen response modulators (raloxifene) are used to ____ and \_\_\_\_
Selective estrogen response modulators (raloxifene) are used to prevent / treat postmenopausal osteoporosis and reduce risk of breast cancer * Adverse effects: thromboses (estrogenic), hot flashes (anti-estrogenic), contraindicated in women who may become pregnant
70
Alendronate, risedronate, zoledronic acid, and ibandronate are \_\_\_\_
Alendronate, risedronate, zoledronic acid, and ibandronate are bisphosphonates * Analogs of pyrophosphate
71
Bisphosphonates ___ and \_\_\_
Bisphosphonates accumulate in bone at sites of active resorption and inhibit osteoclast activity and survival after being taken up * Antiresorptive * Alendronate, risedronate, zoledronic acid, ibandronate
72
Bisphosphonates are used to ____ and treat \_\_\_\_, \_\_\_\_, and \_\_\_\_
Bisphosphonates are used to prevent / treat osteoporosis and treat bone metastases from breast / prostate cancer, hypercalcemia, and Paget's disease
73
Describe adverse effects of bisphosphonates
Adverse effects of bisphosphonates * Heartburn, esophageal irritation, esophagitis * Abdominal pain, diarrhea * Osteonecrosis of the jaw and atypical femoral fractures are rare but serious
74
Denosumab is a ____ that ____ and \_\_\_\_
Denosumab is a human monoclonal antibody against RANKL that inhibits osteoclast fusion, function, and survival (antiresorptive) and increases bone mineral density and decreases fractures * Used to treat osteoporosis
75
Describe adverse effects of denosumab
Denosumab adverse effects * Hypocalcemia * Rashes * Osteonecrosis of jaw * Risk of infections in individuals with weak immune system
76
Describe anti-resorptive therapy for osteoporosis
Anti-resorptive therapy for osteoporosis
77
Describe formation-stimulating (anabolic) therapy for osteoporosis
Formation-stimulating (anabolic) therapy for osteoporosis
78
\_\_\_ and ___ are anabolic (bone formation) therapy for osteoporosis
PTH (teriparatide) and abaloparatide are anabolic (bone formation) therapy for osteoporosis
79
Short term glucocorticoid treatment can reduce ____ through ____ and \_\_\_\_
Short term glucocorticoid treatment can reduce hypercalcemia through decreased intestinal calcium absorption and increased renal calcium excretion
80
Chronic glucocorticoid treatment can cause \_\_\_\_
Chronic glucocorticoid treatment can cause osteoporosis * Decreased intestinal Ca absorption * Increase renal Ca excretion * Increase PTH secretion * Decrease gonadal steroids * Decrease protein synthesis in bone
81
Hypocalcemia is treated with \_\_\_\_, \_\_\_\_, \_\_\_\_, and \_\_\_\_
Hypocalcemia is treated with Vitamin D, caclitriol, alphacalcidol, and thiazide diuretics
82
Hypercalcemia is treated with \_\_\_\_, \_\_\_\_, \_\_\_\_, and \_\_\_\_
Hypercalcemia is treated with loop diuretics, bisphosphonates, calcitonin, and glucocorticoids
83
Antiresorptive treatment for osteoporosis involves \_\_\_\_, \_\_\_\_, \_\_\_\_, \_\_\_\_, and \_\_\_\_
Antiresorptive treatment for osteoporosis involves bisphosphonates, denosumab, selective estrogen receptor modulators, estrogen, and calcitonin (with Ca, Vitamin D, and exercise)
84
Anabolic treatment for osteoporosis involves ____ and \_\_\_\_
Anabolic treatment for osteoporosis involves teriparatide (PTH) and abaloparatide (PTHrP analog) (Ca, Vitamin D, and exercise)
Endo
flashcards
Decks in class (25)
# Cards
Brainscape helps you reach your goals faster, through stronger study habits.
© 2026 Bold Learning Solutions. Terms and Conditions